harnessing car t-cell insights to develop treatments for hyperinflammatory responses in patients with covid-19. ¬© 2020 American Association for Cancer Research.C ytokine release and macrophage activation contribute to immunopathology after SARS-CoV-2 infection. We discuss approaches to decrease the morbidity and mortality in patients with COVID-19 by repurposing existing drugs previously developed for cancer therapy.